Scott Carter - EndoChoice Holdings Director
Director
Mr J. Scott Carter is the Director of the company. He was a member of our board of directors since January 2013. Mr. Carter was a managing member of Sequoia Capital Operations LLC a VC firm since June 2006. He focuses on services software and healthcare investments. He is a Director of AirStrip Technologies Allston Trading Implantable Provider Group SimpliSafe and Telcare. Mr. Carter was previously involved with Sequoias investments in Acton Pharmaceuticals Amertiox eCardio Diagnostics and Merlin Securities. Prior to joining Sequoia Capital Mr. Carter was with Summit Partners where he focused on investments in the financial services and technology sectors. Earlier he was with J.P. Morgan and its predecessor entities and served in various staff positions with former U.S. Senator Phil Gramm. Mr. Carter has a B.A. in Political Science from Texas AM University and an MBA from the Darden School of Business at the University of Virginia since 2013.
| Age | 44 |
| Tenure | 11 years |
| Phone | 888-682-3636 |
| Web | http://www.endochoice.com |
EndoChoice Holdings Management Efficiency
The company has Return on Asset (ROA) of (0.473) % which means that for every 100 dollars spent on asset, it generated a loss of $0.473. This is way below average. EndoChoice Holdings' management efficiency ratios could be used to measure how well EndoChoice Holdings manages its routine affairs as well as how well it operates its assets and liabilities.The company reports 42.64 M of total liabilities with total debt to equity ratio (D/E) of 0.7, which is normal for its line of buisiness. EndoChoice Holdings has a current ratio of 5.52, indicating that it is in good position to pay out its debt commitments in time. Debt can assist EndoChoice Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, EndoChoice Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like EndoChoice Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for EndoChoice to invest in growth at high rates of return. When we think about EndoChoice Holdings' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| William Morral | Univest Pennsylvania | 70 | |
| Tadayoshi Shinozaki | Chiba Bank Ltd | 58 | |
| Yuichi Katayama | Chiba Bank Ltd | N/A | |
| Joon Jyoung | Franklin Wireless Corp | 75 | |
| Shunichi Ishii | Chiba Bank Ltd | N/A | |
| Takayuki Hosokai | Chiba Bank Ltd | N/A | |
| Peggy Scott | Eastern Co | 66 | |
| Richard Edelman | Merit Medical Systems | 73 | |
| Alfred Goldberg | Repligen | 71 | |
| Natalye Paquin | Univest Pennsylvania | 57 | |
| Hitoshi Ikeda | Chiba Bank Ltd | N/A | |
| Michael Stillabower | Merit Medical Systems | 73 | |
| Kazuyoshi Fukushima | Chiba Bank Ltd | N/A | |
| Kent Stanger | Merit Medical Systems | 62 | |
| Toyokuni Yazaki | Chiba Bank Ltd | 77 | |
| Nicolas Barthelemy | Repligen | 51 | |
| Glenn Cooper | Repligen | 64 | |
| Glenn Moyer | Univest Pennsylvania | 66 | |
| Donald Tuttle | Eastern Co | 64 | |
| Shoichi Hatano | Chiba Bank Ltd | 55 | |
| Masahiro Ohwaku | Chiba Bank Ltd | 54 | |
Management Performance
| Return On Asset | -0.47 |
EndoChoice Holdings Leadership Team
Elected by the shareholders, the EndoChoice Holdings' board of directors comprises two types of representatives: EndoChoice Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EndoChoice. The board's role is to monitor EndoChoice Holdings' management team and ensure that shareholders' interests are well served. EndoChoice Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EndoChoice Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Simon MA, CFO | ||
| Scott Huennekens, Chairman of the Board | ||
| David Kaufman, Director | ||
| David Mowry, Director | ||
| Douglas Ladd, Chief Marketing Officer | ||
| Rurik Vandevenne, Director | ||
| Simon Tam, President CEO, Director | ||
| John Smyth, Director | ||
| James Balkcom, Director | ||
| Kevin Rubey, COO | ||
| Mark Gilreath, Founder, CEO and President and Director | ||
| Scott Davis, Director | ||
| Uri Geiger, Director | ||
| Scott Carter, Director | ||
| David Gill, CFO | ||
| Craig Walker, Director | ||
| William Enquist, Director | ||
| Michael Ballanger, Director | ||
| John Barr, Chairman of the Board, Interim CEO | ||
| Eric Schjelderup, Director |
EndoChoice Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EndoChoice Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.47 | |||
| Profit Margin | (0.0001) % | |||
| Operating Margin | (0.0001) % | |||
| Current Valuation | 201.86 M | |||
| Shares Outstanding | 21.08 M | |||
| Shares Owned By Insiders | 13.73 % | |||
| Shares Owned By Institutions | 46.30 % | |||
| Number Of Shares Shorted | 349.75 K | |||
| Price To Earning | (2.96) X | |||
| Price To Book | 3.28 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EndoChoice Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EndoChoice Holdings' short interest history, or implied volatility extrapolated from EndoChoice Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in EndoChoice Stock
If you are still planning to invest in EndoChoice Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EndoChoice Holdings' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |